Perrigo Company 

(Public, NASDAQ:PRGO)   Watch this stock   
Find more results for PRGO
Nov 2, 2009
Q1 2010 Earnings Conference Call
Nov 2, 2009
Q1 2010 Earnings Release
Oct 29, 2009
Shareholders Meeting
Sep 29, 2009
Analyst Day
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2009
Net profit margin 11.56% 7.03%
Operating margin 16.40% 11.57%
EBITD margin - 15.07%
Return on average assets 9.72% 5.52%
Return on average equity 25.87% 15.21%
Employees 7,250 -

Address

515 Eastern Avenue
Allegan, MI 49010
United States - Map
+1-269-6738451 (Phone)
+1-269-6737534 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

Perrigo Company discussed on blogs

Ranking 700+ Mid-Cap Stocks by Upside Potential - NASD100.com ... - Investor's Resources - NASD100.com - Daily Stock Rankings - 14 hours ago

Perrigo Company discussions

  View all discussions »

Description

Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients, and pharmaceutical and medical diagnostic products. The Company operates in three segments: Consumer Healthcare, Rx Pharmaceuticals and API. The Company has other category that consists of the Israel Pharmaceutical and Diagnostic Products. The Company operates through wholly owned subsidiaries. In the United States, its operations are conducted through L. Perrigo Company, Perrigo Company of South Carolina, Inc., Perrigo New York, Inc., Perrigo Holland, Inc. and Perrigo Florida, Inc. Outside the United States, its operations are conducted through Perrigo Israel Pharmaceuticals Ltd., Chemagis Ltd., Quimica y Farmacia S.A. de C.V., Laboratorios Diba, S.A., Wrafton Laboratories Limited, Brunel Pharma Limited and Galpharm Healthcare Ltd.

Officers and directors

Joseph C. Papa
Chairman of the Board, President, Chief Executive Officer
Age: 54
Bio & Compensation - Reuters
Judy L. Brown
Chief Financial Officer, Executive Vice President
Age: 41
Bio & Compensation - Reuters
Todd W. Kingma
Executive Vice President, General Counsel, Secretary
Age: 49
Bio & Compensation - Reuters
John T. Hendrickson
Executive Vice President - Global Operations and Supply Chain
Age: 46
Bio & Compensation - Reuters
Refael Lebel
Executive Vice President and President, Perrigo Israel
Age: 52
Bio & Compensation - Reuters
Sharon Kochan
Executive Vice President - U.S. Generics
Age: 41
Bio & Compensation - Reuters
Thomas M. Farrington
Senior Vice President, Chief Information Officer
Age: 52
Bio & Compensation - Reuters
Jatin Shah Ph.D.
Senior Vice President, Chief Scientific Officer
Age: 56
Bio & Compensation - Reuters
James C. Tomshack
Senior Vice President - Consumer Healthcare Sales
Age: 58
Bio & Compensation - Reuters
Michael R. Stewart
Senior Vice President - Global Human Resources
Age: 57
Bio & Compensation - Reuters